Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
GAITHERSBURG, Md., May 2 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced that, in connection with the previously...
GAITHERSBURG, Md., May 2 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced that seven abstracts will be presented at the...
GAITHERSBURG, Md., April 30 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) announced today that a 15-percent increase in total revenues...
- New Compound Targeting Receptor Tyrosine Kinase EphA2 Shows Tumor Destruction at Low Dose Levels in Preclinical Models - GAITHERSBURG, Md. and...
- Preclinical Data Support Rationale for Targeting Pro-Inflammatory Protein - GAITHERSBURG, Md., April 18 /PRNewswire-FirstCall/ -- MedImmune...
GAITHERSBURG, Md. and CARLSBAD, Calif., April 18 /PRNewswire-FirstCall/ -- Micromet, Inc. (NASDAQ:MITI) and MedImmune, Inc. (NASDAQ:MEDI) today...
New York, April 16 /PRNewswire/ -- Several weeks ago, as a large shareholder of MedImmune, Inc. (NASDAQ:MEDI), Carl Icahn informed the company...
GAITHERSBURG, Md., April 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced that its board of directors has authorized...
Company Invites Investors to Participate in First-Quarter 2007 Earnings Conference Call on May 3, 2007 GAITHERSBURG, Md., April 9...
-- Experts Recognized for their Expanded Strategic Contributions in Driving Pipeline Progress GAITHERSBURG, Md., April 2 /PRNewswire-FirstCall/...
GAITHERSBURG, Md., April 2 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) announced today that Robert H. Hotz has been appointed to its...
CHICAGO, March 30 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks. Seven Summits Strategic Investments...
GAITHERSBURG, Md., March 29 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) announced today that it has licensed its proprietary reverse...
GAITHERSBURG, Md., March 23 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced that it has initiated a Phase 1 trial with...
CHICAGO, March 16 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks. Seven Summits Strategic Investments...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지